Market
What will be Sanofi's market share in China's insulin market by end of 2026?
2
Resolution / Starting Odds
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Industry reports or market analysis from reputable sources
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Largest Single Investment for Beijing Insulin Production
Dec 2, 2024, 04:39 PM
Sanofi, the French pharmaceutical company, has announced plans to invest approximately 1 billion euros ($1.05 billion) to establish a new insulin production facility in Beijing. This investment marks Sanofi's largest single investment in China to date. The announcement follows a meeting between China's Commerce Minister Wang Wentao and Sanofi's Chairman Frédéric Oudéa, where Wang emphasized China's commitment to providing a favorable business environment for pharmaceutical companies. This development comes amid ongoing trade tensions between China and the European Union, highlighting Sanofi's strategic move to strengthen its presence in the Chinese market.
View original story
Similar markets
Remain the same • 25%
Other • 25%
Increase • 25%
Decrease • 25%
No significant change • 25%
Increase by over 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
Novo Nordisk • 25%
Other • 25%
Sanofi • 25%
EMS • 25%
20% to 30% • 25%
10% to 20% • 25%
Less than 10% • 25%
More than 30% • 25%
Production started • 25%
Construction completed • 25%
Construction started • 25%
None of the above • 25%
No • 50%
Yes • 50%
Less than 30% • 25%
More than 50% • 25%
40% to 50% • 25%
30% to 40% • 25%
Other • 25%
Worsened relations • 25%
Improved relations • 25%
No change • 25%
Slightly increase • 25%
Significantly increase • 25%
Decrease • 25%
No change • 25%
More than 30% • 25%
Less than 10% • 25%
20% to 30% • 25%
10% to 20% • 25%